Levocarnitine Injection, Solution
Product Images NDC 68083-681

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levocarnitine (NDC 68083-681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levocarnitine-spl-carton-label.jpg (Levocarnitine Spl Carton Label)

Packaging label for Levocarnitine Injection, USP 1 g/5 mL (200 mg/mL) intravenous solution. The label indicates it is for intravenous use only and to discard unused portion. The package contains five 5 mL single-dose vials. Manufactured by Gland Pharma Limited, India. Includes storage instructions and barcode.*

FDA Label Image

Levocarnitine-spl-container-label.jpg (Levocarnitine Spl Container Label)

Label for Levocarnitine Injection, USP 1 g/5 mL (200 mg/mL) intravenous injection solution in a 5 mL single-dose vial. Manufactured by Gland Pharma Limited, Hyderabad, India. The label includes dosage strength, storage instructions, and cautions to discard unused portion.*

FDA Label Image

Levocarnitine-spl-structure (Levocarnitine Spl Structure)

Chemical structure of levocarnitine, showing a molecular diagram with labeled functional groups including a hydroxyl group (HO), a trimethylammonium group ((CH3)3N+), and a carboxylate group (COO-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.